🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to characterize the safety, immunogenicity, an...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-11-09
Trial ID
NCT00979602
Treatments Being Tested
The purpose of this study is to characterize the safety and immune response...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-20
Trial ID
NCT00976820
Treatments Being Tested
This study is designed to characterize the safety and immunogenicity of a' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-02-09
Trial ID
NCT01059617
The purpose of this study is to show that vaccination with a single dose of...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-02-01
Trial ID
NCT01035749
This study will assess safety and immunogenicity of GSK Biologicals' H5N1 f...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-11-29
Trial ID
NCT01236040
The purpose of this study is to characterize the safety and immunogenicity ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-01
Trial ID
NCT00985673
Treatments Being Tested
The purpose of this study is to characterize the safety and immunogenicity ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-11
Trial ID
NCT00985088
Treatments Being Tested
The purpose of this study is to characterize the safety and efficacy of GSK...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-02-12
Trial ID
NCT01051661